Evidence map›Paper›PMID 38058449›Full record

ArticleHeliyon2023

Both recombinant

Yuxuan Zhang, Yao Wu, Chong Peng, Zixuan Li, Gang Wang, Hui Wang, Lanping Yu, Fangkun Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yuxuan ZhangDepartment of Veterinary Public Health, College of Veterinary Medicine, Shandong Agricultural University, Taian City, Shandong Province, China.
Yao WuDepartment of Veterinary Public Health, College of Veterinary Medicine, Shandong Agricultural University, Taian City, Shandong Province, China.
Chong PengDepartment of Veterinary Public Health, College of Veterinary Medicine, Shandong Agricultural University, Taian City, Shandong Province, China.
Zixuan LiDepartment of Veterinary Public Health, College of Veterinary Medicine, Shandong Agricultural University, Taian City, Shandong Province, China.
Gang WangShandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention, Shandong Agricultural University, Taian City, Shandong Province, China.
Hui WangShandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention, Shandong Agricultural University, Taian City, Shandong Province, China.
Lanping YuShandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention, Shandong Agricultural University, Taian City, Shandong Province, China.
Fangkun WangDepartment of Veterinary Public Health, College of Veterinary Medicine, Shandong Agricultural University, Taian City, Shandong Province, China.
Shandong Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Porcine circovirus type 2 (PCV2) is one of the most serious pathogens in pig herds worldwide. The Capsid protein (Cap), a structural protein of PCV2, is involved in the host's immune response; it induces neutralizing-antibody production and has good immunogenicity. The main PCV2 subtype currently prevalent in the Chinese pig herd is PCV2d. In this study, We constructed a recombinant

Indexed as

Bacillus subtilisCapPCV2dVaccineVLPs

Identifiers

PMID38058449
PMCPMC10696252
OpenAlexW4389100689

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.